Abivax ABVX
NASDAQ ABVX
$91.44 +1.44 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Abivax (ABVX) EBITDA Margin (2024 - 2026)

Updated

Abivax (ABVX) posted EBITDA Margin of -184.69% for Q2 2026, up 644.37 percentage points from -829.06% a year earlier.

Analysis

Abivax (ABVX) EBITDA Margin (2024 - 2026) Analysis & Trends

Since Q1 2024, Abivax has reported EBITDA Margin for 8 quarters.

  • Quarterly EBITDA Margin has run from a low of -19910.15% in Q4 2024 to a high of -83.43% in Q3 2025 over five years.
  • On a year-over-year basis, EBITDA Margin increased in two of the last four quarters, with an average year-over-year change of -234.00 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 32.68%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 46.88%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 40.60%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 39.77%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 46.62%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 50.63%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 42.49%
10 Abivax 7.07 Bn 4.69 Bn - -184.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -184.69%
Mar 31, 2026 -1,032.00%
Sep 30, 2025 -83.43%
Jun 30, 2025 -825.07%
Mar 31, 2025 -618.93%
Sep 30, 2024 -477.61%
Jun 30, 2024 -374.60%
Mar 31, 2024 -657.50%
API Access

Abivax EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ABVX&period=max&api_key=YOUR_API_KEY